Annual CFF
$6.04 M
+$6.02 M+46330.77%
December 31, 2023
Summary
- As of March 10, 2025, ENTX annual cash flow from financing activities is $6.04 million, with the most recent change of +$6.02 million (+46330.77%) on December 31, 2023.
- During the last 3 years, ENTX annual CFF has risen by +$1.99 million (+49.00%).
- ENTX annual CFF is now -76.22% below its all-time high of $25.38 million, reached on December 31, 2021.
Performance
ENTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$13.00 K
-$1.20 M-98.93%
September 30, 2024
Summary
- As of March 10, 2025, ENTX quarterly cash flow from financing activities is $13.00 thousand, with the most recent change of -$1.20 million (-98.93%) on September 30, 2024.
- Over the past year, ENTX quarterly CFF has stayed the same.
- ENTX quarterly CFF is now -99.90% below its all-time high of $12.67 million, reached on June 30, 2021.
Performance
ENTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$7.29 M
+$13.00 K+0.18%
September 30, 2024
Summary
- As of March 10, 2025, ENTX TTM cash flow from financing activities is $7.29 million, with the most recent change of +$13.00 thousand (+0.18%) on September 30, 2024.
- Over the past year, ENTX TTM CFF has stayed the same.
- ENTX TTM CFF is now -74.37% below its all-time high of $28.45 million, reached on September 30, 2021.
Performance
ENTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ENTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | 0.0% | 0.0% |
| 3 y3 years | +49.0% | +160.0% | +10000.0% |
| 5 y5 years | -37.3% | +160.0% | +10000.0% |
ENTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -76.2% | >+9999.0% | -99.8% | -100.0% | -71.3% | >+9999.0% |
| 5 y | 5-year | -76.2% | >+9999.0% | -99.9% | +137.1% | -74.4% | >+9999.0% |
| alltime | all time | -76.2% | >+9999.0% | -99.9% | +137.1% | -74.4% | -100.0% |
Entera Bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.00 K(-98.9%) | $7.29 M(+0.2%) |
| Jun 2024 | - | $1.22 M(+3953.3%) | $7.28 M(+20.0%) |
| Mar 2024 | - | $30.00 K(-99.5%) | $6.07 M(+0.5%) |
| Dec 2023 | $6.04 M(>+9900.0%) | $6.03 M(>+9900.0%) | $6.04 M(>+9900.0%) |
| Sep 2023 | - | $0.00(-100.0%) | $5000.00(0.0%) |
| Jun 2023 | - | $5000.00(>+9900.0%) | $5000.00(-61.5%) |
| Mar 2023 | - | $0.00(0.0%) | $13.00 K(0.0%) |
| Dec 2022 | $13.00 K(-99.9%) | $0.00(0.0%) | $13.00 K(-61.8%) |
| Sep 2022 | - | $0.00(-100.0%) | $34.00 K(-98.7%) |
| Jun 2022 | - | $13.00 K(-38.1%) | $2.62 M(-89.7%) |
| Dec 2021 | $25.38 M(+526.5%) | $21.00 K(-99.2%) | $25.38 M(-10.8%) |
| Sep 2021 | - | $2.58 M(-79.6%) | $28.45 M(+9.3%) |
| Jun 2021 | - | $12.67 M(+25.3%) | $26.03 M(+95.3%) |
| Mar 2021 | - | $10.11 M(+227.5%) | $13.33 M(+229.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $4.05 M(-68.0%) | $3.09 M(+1705.3%) | $4.05 M(-69.9%) |
| Sep 2020 | - | $171.00 K(-588.6%) | $13.46 M(-0.1%) |
| Jun 2020 | - | -$35.00 K(-104.2%) | $13.47 M(-0.2%) |
| Mar 2020 | - | $828.00 K(-93.4%) | $13.50 M(+6.7%) |
| Dec 2019 | $12.65 M(+31.5%) | $12.50 M(+6765.9%) | $12.65 M(+8010.3%) |
| Sep 2019 | - | $182.00 K(-6166.7%) | $156.00 K(-98.4%) |
| Jun 2019 | - | -$3000.00(-87.0%) | $9.60 M(-0.0%) |
| Mar 2019 | - | -$23.00 K(<-9900.0%) | $9.60 M(-0.2%) |
| Dec 2018 | $9.62 M(-13.4%) | $0.00(-100.0%) | $9.62 M(0.0%) |
| Sep 2018 | - | $9.62 M(>+9900.0%) | $9.62 M(>+9900.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $11.11 M(+53.9%) | - | - |
| Dec 2016 | $7.22 M(+61.6%) | - | - |
| Dec 2015 | $4.46 M | - | - |
FAQ
- What is Entera Bio annual cash flow from financing activities?
- What is the all time high annual CFF for Entera Bio?
- What is Entera Bio annual CFF year-on-year change?
- What is Entera Bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Entera Bio?
- What is Entera Bio quarterly CFF year-on-year change?
- What is Entera Bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for Entera Bio?
- What is Entera Bio TTM CFF year-on-year change?
What is Entera Bio annual cash flow from financing activities?
The current annual CFF of ENTX is $6.04 M
What is the all time high annual CFF for Entera Bio?
Entera Bio all-time high annual cash flow from financing activities is $25.38 M
What is Entera Bio annual CFF year-on-year change?
Over the past year, ENTX annual cash flow from financing activities has changed by +$6.02 M (+46330.77%)
What is Entera Bio quarterly cash flow from financing activities?
The current quarterly CFF of ENTX is $13.00 K
What is the all time high quarterly CFF for Entera Bio?
Entera Bio all-time high quarterly cash flow from financing activities is $12.67 M
What is Entera Bio quarterly CFF year-on-year change?
Over the past year, ENTX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Entera Bio TTM cash flow from financing activities?
The current TTM CFF of ENTX is $7.29 M
What is the all time high TTM CFF for Entera Bio?
Entera Bio all-time high TTM cash flow from financing activities is $28.45 M
What is Entera Bio TTM CFF year-on-year change?
Over the past year, ENTX TTM cash flow from financing activities has changed by $0.00 (0.00%)